List of Tables
Table 1. Global HPV Genetically Engineered Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global HPV Genetically Engineered Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global HPV Genetically Engineered Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global HPV Genetically Engineered Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global HPV Genetically Engineered Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global HPV Genetically Engineered Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global HPV Genetically Engineered Vaccine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market HPV Genetically Engineered Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of HPV Genetically Engineered Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of HPV Genetically Engineered Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of HPV Genetically Engineered Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of HPV Genetically Engineered Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global HPV Genetically Engineered Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HPV Genetically Engineered Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global HPV Genetically Engineered Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global HPV Genetically Engineered Vaccine Sales by Region (2020-2025) & (K Units)
Table 18. Global HPV Genetically Engineered Vaccine Sales Market Share by Region (2020-2025)
Table 19. Global HPV Genetically Engineered Vaccine Sales by Region (2026-2031) & (K Units)
Table 20. Global HPV Genetically Engineered Vaccine Sales Market Share by Region (2026-2031)
Table 21. Global HPV Genetically Engineered Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global HPV Genetically Engineered Vaccine Revenue Market Share by Region (2020-2025)
Table 23. Global HPV Genetically Engineered Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global HPV Genetically Engineered Vaccine Revenue Market Share by Region (2026-2031)
Table 25. North America HPV Genetically Engineered Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America HPV Genetically Engineered Vaccine Sales by Country (2020-2025) & (K Units)
Table 27. North America HPV Genetically Engineered Vaccine Sales by Country (2026-2031) & (K Units)
Table 28. North America HPV Genetically Engineered Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America HPV Genetically Engineered Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe HPV Genetically Engineered Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe HPV Genetically Engineered Vaccine Sales by Country (2020-2025) & (K Units)
Table 32. Europe HPV Genetically Engineered Vaccine Sales by Country (2026-2031) & (K Units)
Table 33. Europe HPV Genetically Engineered Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe HPV Genetically Engineered Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific HPV Genetically Engineered Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific HPV Genetically Engineered Vaccine Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific HPV Genetically Engineered Vaccine Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific HPV Genetically Engineered Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific HPV Genetically Engineered Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America HPV Genetically Engineered Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America HPV Genetically Engineered Vaccine Sales by Country (2020-2025) & (K Units)
Table 42. Latin America HPV Genetically Engineered Vaccine Sales by Country (2026-2031) & (K Units)
Table 43. Latin America HPV Genetically Engineered Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America HPV Genetically Engineered Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa HPV Genetically Engineered Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa HPV Genetically Engineered Vaccine Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa HPV Genetically Engineered Vaccine Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa HPV Genetically Engineered Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa HPV Genetically Engineered Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global HPV Genetically Engineered Vaccine Sales (K Units) by Type (2020-2025)
Table 51. Global HPV Genetically Engineered Vaccine Sales (K Units) by Type (2026-2031)
Table 52. Global HPV Genetically Engineered Vaccine Sales Market Share by Type (2020-2025)
Table 53. Global HPV Genetically Engineered Vaccine Sales Market Share by Type (2026-2031)
Table 54. Global HPV Genetically Engineered Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global HPV Genetically Engineered Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global HPV Genetically Engineered Vaccine Revenue Market Share by Type (2020-2025)
Table 57. Global HPV Genetically Engineered Vaccine Revenue Market Share by Type (2026-2031)
Table 58. Global HPV Genetically Engineered Vaccine Price (US$/Unit) by Type (2020-2025)
Table 59. Global HPV Genetically Engineered Vaccine Price (US$/Unit) by Type (2026-2031)
Table 60. Global HPV Genetically Engineered Vaccine Sales (K Units) by Application (2020-2025)
Table 61. Global HPV Genetically Engineered Vaccine Sales (K Units) by Application (2026-2031)
Table 62. Global HPV Genetically Engineered Vaccine Sales Market Share by Application (2020-2025)
Table 63. Global HPV Genetically Engineered Vaccine Sales Market Share by Application (2026-2031)
Table 64. Global HPV Genetically Engineered Vaccine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global HPV Genetically Engineered Vaccine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global HPV Genetically Engineered Vaccine Revenue Market Share by Application (2020-2025)
Table 67. Global HPV Genetically Engineered Vaccine Revenue Market Share by Application (2026-2031)
Table 68. Global HPV Genetically Engineered Vaccine Price (US$/Unit) by Application (2020-2025)
Table 69. Global HPV Genetically Engineered Vaccine Price (US$/Unit) by Application (2026-2031)
Table 70. Merck & Co., Inc. Company Information
Table 71. Merck & Co., Inc. Description and Business Overview
Table 72. Merck & Co., Inc. HPV Genetically Engineered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Merck & Co., Inc. HPV Genetically Engineered Vaccine Product
Table 74. Merck & Co., Inc. Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK HPV Genetically Engineered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. GSK HPV Genetically Engineered Vaccine Product
Table 79. GSK Recent Developments/Updates
Table 80. Walvax Biotechnology Co.,Ltd. Company Information
Table 81. Walvax Biotechnology Co.,Ltd. Description and Business Overview
Table 82. Walvax Biotechnology Co.,Ltd. HPV Genetically Engineered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Walvax Biotechnology Co.,Ltd. HPV Genetically Engineered Vaccine Product
Table 84. Walvax Biotechnology Co.,Ltd. Recent Developments/Updates
Table 85. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Company Information
Table 86. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Description and Business Overview
Table 87. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. HPV Genetically Engineered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. HPV Genetically Engineered Vaccine Product
Table 89. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Recent Developments/Updates
Table 90. Sanofi Pasteur Company Information
Table 91. Sanofi Pasteur Description and Business Overview
Table 92. Sanofi Pasteur HPV Genetically Engineered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Sanofi Pasteur HPV Genetically Engineered Vaccine Product
Table 94. Sanofi Pasteur Recent Developments/Updates
Table 95. Serum Institute Company Information
Table 96. Serum Institute Description and Business Overview
Table 97. Serum Institute HPV Genetically Engineered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Serum Institute HPV Genetically Engineered Vaccine Product
Table 99. Serum Institute Recent Developments/Updates
Table 100. Shanghai Zerun Biological Technology Co., Ltd. Company Information
Table 101. Shanghai Zerun Biological Technology Co., Ltd. Description and Business Overview
Table 102. Shanghai Zerun Biological Technology Co., Ltd. HPV Genetically Engineered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Shanghai Zerun Biological Technology Co., Ltd. HPV Genetically Engineered Vaccine Product
Table 104. Shanghai Zerun Biological Technology Co., Ltd. Recent Developments/Updates
Table 105. Shanghai Bovax Biotechnology Co., Ltd. Company Information
Table 106. Shanghai Bovax Biotechnology Co., Ltd. Description and Business Overview
Table 107. Shanghai Bovax Biotechnology Co., Ltd. HPV Genetically Engineered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Shanghai Bovax Biotechnology Co., Ltd. HPV Genetically Engineered Vaccine Product
Table 109. Shanghai Bovax Biotechnology Co., Ltd. Recent Developments/Updates
Table 110. Beijing Health Guard Biotechnology Inc. Company Information
Table 111. Beijing Health Guard Biotechnology Inc. Description and Business Overview
Table 112. Beijing Health Guard Biotechnology Inc. HPV Genetically Engineered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Beijing Health Guard Biotechnology Inc. HPV Genetically Engineered Vaccine Product
Table 114. Beijing Health Guard Biotechnology Inc. Recent Developments/Updates
Table 115. Jiangsu Recbio Technology Co., Ltd. Company Information
Table 116. Jiangsu Recbio Technology Co., Ltd. Description and Business Overview
Table 117. Jiangsu Recbio Technology Co., Ltd. HPV Genetically Engineered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Jiangsu Recbio Technology Co., Ltd. HPV Genetically Engineered Vaccine Product
Table 119. Jiangsu Recbio Technology Co., Ltd. Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. HPV Genetically Engineered Vaccine Distributors List
Table 123. HPV Genetically Engineered Vaccine Customers List
Table 124. HPV Genetically Engineered Vaccine Market Trends
Table 125. HPV Genetically Engineered Vaccine Market Drivers
Table 126. HPV Genetically Engineered Vaccine Market Challenges
Table 127. HPV Genetically Engineered Vaccine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of HPV Genetically Engineered Vaccine
Figure 2. Global HPV Genetically Engineered Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global HPV Genetically Engineered Vaccine Market Share by Type: 2024 & 2031
Figure 4. Bivalent HPV Vaccine Product Picture
Figure 5. Quadrivalent HPV Vaccine Product Picture
Figure 6. 9-valent HPV Vaccine Product Picture
Figure 7. Global HPV Genetically Engineered Vaccine Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global HPV Genetically Engineered Vaccine Market Share by Application: 2024 & 2031
Figure 9. Male
Figure 10. Female
Figure 11. Global HPV Genetically Engineered Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global HPV Genetically Engineered Vaccine Market Size (2020-2031) & (US$ Million)
Figure 13. Global HPV Genetically Engineered Vaccine Sales (2020-2031) & (K Units)
Figure 14. Global HPV Genetically Engineered Vaccine Average Price (US$/Unit) & (2020-2031)
Figure 15. HPV Genetically Engineered Vaccine Report Years Considered
Figure 16. HPV Genetically Engineered Vaccine Sales Share by Manufacturers in 2024
Figure 17. Global HPV Genetically Engineered Vaccine Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest HPV Genetically Engineered Vaccine Players: Market Share by Revenue in HPV Genetically Engineered Vaccine in 2024
Figure 19. HPV Genetically Engineered Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global HPV Genetically Engineered Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America HPV Genetically Engineered Vaccine Sales Market Share by Country (2020-2031)
Figure 22. North America HPV Genetically Engineered Vaccine Revenue Market Share by Country (2020-2031)
Figure 23. United States HPV Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada HPV Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe HPV Genetically Engineered Vaccine Sales Market Share by Country (2020-2031)
Figure 26. Europe HPV Genetically Engineered Vaccine Revenue Market Share by Country (2020-2031)
Figure 27. Germany HPV Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France HPV Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. HPV Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy HPV Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia HPV Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific HPV Genetically Engineered Vaccine Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific HPV Genetically Engineered Vaccine Revenue Market Share by Region (2020-2031)
Figure 34. China HPV Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan HPV Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea HPV Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India HPV Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia HPV Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan HPV Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia HPV Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America HPV Genetically Engineered Vaccine Sales Market Share by Country (2020-2031)
Figure 42. Latin America HPV Genetically Engineered Vaccine Revenue Market Share by Country (2020-2031)
Figure 43. Mexico HPV Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil HPV Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina HPV Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa HPV Genetically Engineered Vaccine Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa HPV Genetically Engineered Vaccine Revenue Market Share by Country (2020-2031)
Figure 48. Turkey HPV Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia HPV Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE HPV Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of HPV Genetically Engineered Vaccine by Type (2020-2031)
Figure 52. Global Revenue Market Share of HPV Genetically Engineered Vaccine by Type (2020-2031)
Figure 53. Global HPV Genetically Engineered Vaccine Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of HPV Genetically Engineered Vaccine by Application (2020-2031)
Figure 55. Global Revenue Market Share of HPV Genetically Engineered Vaccine by Application (2020-2031)
Figure 56. Global HPV Genetically Engineered Vaccine Price (US$/Unit) by Application (2020-2031)
Figure 57. HPV Genetically Engineered Vaccine Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
